Clinical significance of epidermal growth factor receptor mutations in resected stage IA non-small cell lung cancer

Clinical significance of epidermal growth factor receptor mutations in resected stage IA non-small cell lung cancer

Background: Epidermal growth factor receptor (EGFR) gene mutation is a known predictor of the response to EGFR tyrosine kinase inhibitors. However, detecting EGFR mutations is a potential challenge because of the ground-glass opacity component, and its prognostic value for stage IA lung adenocarcino...

Full description

Bibliographic Details
Main Authors: Yuan-Ming Tsai, Kuan-Hsun Lin, Yen-Shou Kuo, Yu-Chieh Lin, Yu-Hsin Chien, Hsiu-Ping Chou, Ying-Yi Chen, Hsu-Kai Huang, Ti-Hui Wu, Hung Chang, Shih-Chun Lee, Tsai-Wang Huang
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2022-01-01
Series:Formosan Journal of Surgery
Subjects:
age
epidermal growth factor receptor
lung adenocarcinoma
overall survival
prognosis
stage ia
Online Access:http://www.e-fjs.org/article.asp?issn=1682-606X;year=2022;volume=55;issue=3;spage=109;epage=115;aulast=Tsai

Internet

http://www.e-fjs.org/article.asp?issn=1682-606X;year=2022;volume=55;issue=3;spage=109;epage=115;aulast=Tsai

Similar Items